Burani, Al-yasher .

HRN: 27-82-54  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/20/2025
09/27/2025
IV
420mg
Q6
1.PCAP C 2. AGE With Mod DHN 3.CHD TOD
Checking Initial Appropriateness 
09/21/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/21/2025
10/01/2025
PO
4ml
Q 8 Hours
T/C Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: